199 related articles for article (PubMed ID: 8360934)
21. p53 and Ki-ras gene mutations in epithelial ovarian neoplasms.
Teneriello MG; Ebina M; Linnoila RI; Henry M; Nash JD; Park RC; Birrer MJ
Cancer Res; 1993 Jul; 53(13):3103-8. PubMed ID: 8319218
[TBL] [Abstract][Full Text] [Related]
22. p53 gene mutations in human gastric cancer: wild-type p53 but not mutant p53 suppresses growth of human gastric cancer cells.
Matozaki T; Sakamoto C; Suzuki T; Matsuda K; Uchida T; Nakano O; Wada K; Nishisaki H; Konda Y; Nagao M
Cancer Res; 1992 Aug; 52(16):4335-41. PubMed ID: 1322785
[TBL] [Abstract][Full Text] [Related]
23. p53 mutation is a common genetic event in ovarian carcinoma.
Milner BJ; Allan LA; Eccles DM; Kitchener HC; Leonard RC; Kelly KF; Parkin DE; Haites NE
Cancer Res; 1993 May; 53(9):2128-32. PubMed ID: 8481915
[TBL] [Abstract][Full Text] [Related]
24. A comparative study of p53 gene mutations, protein accumulation, and response to cisplatin-based chemotherapy in advanced ovarian carcinoma.
Righetti SC; Della Torre G; Pilotti S; Ménard S; Ottone F; Colnaghi MI; Pierotti MA; Lavarino C; Cornarotti M; Oriana S; Böhm S; Bresciani GL; Spatti G; Zunino F
Cancer Res; 1996 Feb; 56(4):689-93. PubMed ID: 8630996
[TBL] [Abstract][Full Text] [Related]
25. Exon 5 of the p53 gene is a target for deletions in ovarian cancer.
Angelopoulou K; Levesque MA; Katsaros D; Shipman R; Diamandis EP
Clin Chem; 1998 Jan; 44(1):72-7. PubMed ID: 9550561
[TBL] [Abstract][Full Text] [Related]
26. Missense mutations and a deletion of the p53 gene in human gastric cancer.
Matozaki T; Sakamoto C; Matsuda K; Suzuki T; Konda Y; Nakano O; Wada K; Uchida T; Nishisaki H; Nagao M
Biochem Biophys Res Commun; 1992 Jan; 182(1):215-23. PubMed ID: 1370612
[TBL] [Abstract][Full Text] [Related]
27. Relationship between lifetime ovulatory cycles and overexpression of mutant p53 in epithelial ovarian cancer.
Schildkraut JM; Bastos E; Berchuck A
J Natl Cancer Inst; 1997 Jul; 89(13):932-8. PubMed ID: 9214672
[TBL] [Abstract][Full Text] [Related]
28. Mutations in the p53 gene occur in diverse human tumour types.
Nigro JM; Baker SJ; Preisinger AC; Jessup JM; Hostetter R; Cleary K; Bigner SH; Davidson N; Baylin S; Devilee P
Nature; 1989 Dec; 342(6250):705-8. PubMed ID: 2531845
[TBL] [Abstract][Full Text] [Related]
29. p53 mutations in human lung tumors.
Miller CW; Simon K; Aslo A; Kok K; Yokota J; Buys CH; Terada M; Koeffler HP
Cancer Res; 1992 Apr; 52(7):1695-8. PubMed ID: 1312896
[TBL] [Abstract][Full Text] [Related]
30. Mutation analysis of the BRCA1 gene in ovarian cancers.
Takahashi H; Behbakht K; McGovern PE; Chiu HC; Couch FJ; Weber BL; Friedman LS; King MC; Furusato M; LiVolsi VA
Cancer Res; 1995 Jul; 55(14):2998-3002. PubMed ID: 7606717
[TBL] [Abstract][Full Text] [Related]
31. Absence of significant germ line p53 mutations in ovarian cancer patients.
Buller RE; Skilling JS; Kaliszewski S; Niemann T; Anderson B
Gynecol Oncol; 1995 Sep; 58(3):368-74. PubMed ID: 7672703
[TBL] [Abstract][Full Text] [Related]
32. Multiplex PCR screening detects small p53 deletions and insertions in human ovarian cancer cell lines.
Runnebaum IB; Tong XW; Moebus V; Heilmann V; Kieback DG; Kreienberg R
Hum Genet; 1994 Jun; 93(6):620-4. PubMed ID: 8005584
[TBL] [Abstract][Full Text] [Related]
33. Association between cisplatin resistance and mutation of p53 gene and reduced bax expression in ovarian carcinoma cell systems.
Perego P; Giarola M; Righetti SC; Supino R; Caserini C; Delia D; Pierotti MA; Miyashita T; Reed JC; Zunino F
Cancer Res; 1996 Feb; 56(3):556-62. PubMed ID: 8564971
[TBL] [Abstract][Full Text] [Related]
34. Novel germline mutations in breast cancer susceptibility genes BRCA1, BRCA2 and p53 gene in breast cancer patients from India.
Hedau S; Jain N; Husain SA; Mandal AK; Ray G; Shahid M; Kant R; Gupta V; Shukla NK; Deo SS; Das BC
Breast Cancer Res Treat; 2004 Nov; 88(2):177-86. PubMed ID: 15564800
[TBL] [Abstract][Full Text] [Related]
35. Overexpression and mutation of p53 in epithelial ovarian cancer.
Marks JR; Davidoff AM; Kerns BJ; Humphrey PA; Pence JC; Dodge RK; Clarke-Pearson DL; Iglehart JD; Bast RC; Berchuck A
Cancer Res; 1991 Jun; 51(11):2979-84. PubMed ID: 2032235
[TBL] [Abstract][Full Text] [Related]
36. p53 in prostate cancer: frequent expressed transition mutations.
Chi SG; deVere White RW; Meyers FJ; Siders DB; Lee F; Gumerlock PH
J Natl Cancer Inst; 1994 Jun; 86(12):926-33. PubMed ID: 7515114
[TBL] [Abstract][Full Text] [Related]
37. High incidence of p53 gene mutation in human ovarian cancer and its association with nuclear accumulation of p53 protein and tumor DNA aneuploidy.
Kihana T; Tsuda H; Teshima S; Okada S; Matsuura S; Hirohashi S
Jpn J Cancer Res; 1992 Sep; 83(9):978-84. PubMed ID: 1429209
[TBL] [Abstract][Full Text] [Related]
38. High frequency of deletion mutations in p53 gene from squamous cell lung cancer patients in Taiwan.
Wang YC; Chen CY; Chen SK; Cherng SH; Ho WL; Lee H
Cancer Res; 1998 Jan; 58(2):328-33. PubMed ID: 9443413
[TBL] [Abstract][Full Text] [Related]
39. Identification of deletions and insertions in the p53 gene using multiplex PCR and high-resolution fragment analysis: application to breast and ovarian tumors.
Angelopoulou K; Diamandis EP
J Clin Lab Anal; 1998; 12(4):250-6. PubMed ID: 9671178
[TBL] [Abstract][Full Text] [Related]
40. Abnormal structure and expression of the p53 gene in human ovarian carcinoma cell lines.
Yaginuma Y; Westphal H
Cancer Res; 1992 Aug; 52(15):4196-9. PubMed ID: 1638534
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
